Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Other financing activities (2016 - 2017)

Historic Other financing activities for Lisata Therapeutics (LSTA) over the last 4 years, with Q4 2017 value amounting to $231.0.

  • Lisata Therapeutics' Other financing activities fell 9953.28% to $231.0 in Q4 2017 from the same period last year, while for Sep 2018 it was $231.0, marking a year-over-year increase of 10093.2%. This contributed to the annual value of -$74000.0 for FY2017, which is 10185.43% down from last year.
  • As of Q4 2017, Lisata Therapeutics' Other financing activities stood at $231.0, which was down 9953.28% from $42314.0 recorded in Q2 2017.
  • Lisata Therapeutics' 5-year Other financing activities high stood at $49446.0 for Q4 2016, and its period low was -$138127.0 during Q3 2016.